TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2/12/26 17:24 | 2/12/26 | AVTR | Avantor, Inc. | Electr | LabEq | Laboratory Analytical Instrum | Summe Gregory L | PA | D | 1 | P | 940 | 9.40 | 0 | 100 | 28 | 458 | I | ||||||||||||||||
2/11/26 16:04 | 2/9/26 | ILMN | Illumina, Inc. | DE | Electr | LabEq | Laboratory Analytical Instrum | Gottlieb Scott | CA | D | 1 | P | 24 | 117.81 | 0 | 0 | 2 | 13 | D | |||||||||||||||
1/20/26 16:22 | 1/2/26 | PRPO | Precipio, Inc. | DE | Electr | LabEq | Laboratory Analytical Instrum | Sabet Ahmed Zaki | CT | O | COO | 4 | P.d | 2 | 20.09 | 0 | 0 | 10 | 1 | D | ||||||||||||||
12/18/25 16:13 | 12/17/25 | SCND | Scientific Industries Inc | DE | Electr | LabEq | Laboratory Analytical Instrum | Moore John A | DE | DO | CB | 3 | P | 22 | 0.5736 | 0 | 38 | 6 | 663 | D | ||||||||||||||
12/9/25 17:11 | 12/5/25 | AVTR | Avantor, Inc. | Electr | LabEq | Laboratory Analytical Instrum | Mehra Sanjeev K | PA | D | 1 | P | 3,882 | 11.09 | 0 | 350 | 999% | 358 | M | ||||||||||||||||
12/4/25 20:59 | 12/2/25 | LAB | Standard Biotools Inc. | DE | Electr | LabEq | Laboratory Analytical Instrum | Casdin Partners Master Fund, L.P. | NY | DT | 2 | P.m | 10,556 | 1.31 | 0 | 8,050 | 10 | 91,685 | I |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |